MR编号 | IS/H/0609/002 |
---|
药品名称 | Nintedanib Teva |
---|
活性成分 | - nintedanib esilate 150.0 mg
|
---|
剂型 | Capsule, soft |
---|
上市许可持有人 | Teva GmbH,
Graf-Arco-Str.3,
89079 Ulm,
Germany |
---|
参考成员国 - 产品名称 | Iceland (IS) Nintedanib Teva |
---|
互认成员国 - 产品名称 | - Italy (IT)
- Slovakia (SK)
- Romania (RO)
Nintedanib Adalvo 150 mg capsule moi - Spain (ES)
- Czechia (CZ)
Nintedanib Adalvo - France (FR)
- Estonia (EE)
- Austria (AT)
- Lithuania (LT)
Nintedanib Adalvo 150 mg minkštosios kapsulės - Luxembourg (LU)
- Latvia (LV)
- Netherlands (NL)
- Slovenia (SI)
- Poland (PL)
Nintedanib Adalvo - Cyprus (CY)
Nintedanib/Teva 150mg soft capsules - Finland (FI)
- Denmark (DK)
- Hungary (HU)
Nintedanib Teva 150mg lágy kapszula - Norway (NO)
- Germany (DE)
Nintedanib Adalvo 150 mg Weichkapseln - Sweden (SE)
- Ireland (IE)
- Greece (GR)
- Croatia (HR)
- Belgium (BE)
Nintedanib Teva 150 mg zachte capsules - Portugal (PT)
|
---|
许可日期 | 2023/12/21 |
---|
最近更新日期 | 2025/01/13 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:Abridged
- TypeLevel2:Initial Application
- TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|